Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number3
DOIs
StatePublished - Jan 1 2004

Fingerprint

Rifamycins
Reverse Transcriptase Inhibitors
Protease Inhibitors
Tuberculosis
HIV
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{1e19b19f7e4941a5ad094941fcdf1d97,
title = "Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors",
author = "John Bartlett",
year = "2004",
month = "1",
day = "1",
doi = "10.1097/01.idc.0000129851.34508.48",
language = "English (US)",
volume = "12",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

AU - Bartlett, John

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026144372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026144372&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000129851.34508.48

DO - 10.1097/01.idc.0000129851.34508.48

M3 - Article

VL - 12

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 3

ER -